ENDRA Life Sciences Inc. (NDRA) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

ENDRA Life Sciences Inc.

NASDAQ: NDRA · Real-Time Price · USD
4.20
-0.06 (-1.41%)
At close: Sep 05, 2025, 3:59 PM
4.68
11.56%
Pre-market: Sep 08, 2025, 08:10 AM EDT

ENDRA Life Sciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
206.17K 275.45K 234.26K 224.41K
Gross Profit
-206.17K -275.45K -234.26K -224.41K
Operating Income
-18.14M -10.52M -13.16M -11.5M
Interest Income
n/a n/a n/a n/a
Pretax Income
-11.51M -10.06M -13.18M -11.23M
Net Income
-11.51M -10.06M -13.2M -11.19M
Selling & General & Admin
7.63M 5.52M 6.6M 6.02M
Research & Development
3.19M 5M 6.55M 5.48M
Other Expenses
n/a 0.00 -21.53K -41.55K
Operating Expenses
10.82M 10.25M 13.16M 11.5M
Interest Expense
n/a n/a 21.53K n/a
Selling & Marketing Expenses
571.04K 820.55K 1.43M 1.08M
Cost & Expenses
18.14M 10.52M 13.16M 11.5M
Income Tax Expense
n/a n/a 21.53K -41.55K
Shares Outstanding (Basic)
1.12M 1.71M 1.93M 2.05M
Shares Outstanding (Diluted)
1.12M 1.71M 1.93M 2.05M
EPS (Basic)
-10.25 -5.89 -4.57 -5.47
EPS (Diluted)
-10.25 -5.89 -6.84 -5.47
EBITDA
-11.3M -10.4M -12.94M -11.01M
EBIT
-11.51M -10.06M -13.18M -11.23M
Depreciation & Amortization
206.17K 275.45K 234.26K 224.41K